Correlation Between Sartorius Stedim and Grand Vision

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and Grand Vision at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and Grand Vision into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sartorius Stedim Biotech and Grand Vision Media, you can compare the effects of market volatilities on Sartorius Stedim and Grand Vision and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of Grand Vision. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and Grand Vision.

Diversification Opportunities for Sartorius Stedim and Grand Vision

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Sartorius and Grand is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and Grand Vision Media in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Grand Vision Media and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with Grand Vision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Grand Vision Media has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and Grand Vision go up and down completely randomly.

Pair Corralation between Sartorius Stedim and Grand Vision

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to generate 0.93 times more return on investment than Grand Vision. However, Sartorius Stedim Biotech is 1.08 times less risky than Grand Vision. It trades about -0.01 of its potential returns per unit of risk. Grand Vision Media is currently generating about -0.03 per unit of risk. If you would invest  31,128  in Sartorius Stedim Biotech on October 14, 2024 and sell it today you would lose (11,185) from holding Sartorius Stedim Biotech or give up 35.93% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Sartorius Stedim Biotech  vs.  Grand Vision Media

 Performance 
       Timeline  
Sartorius Stedim Biotech 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Sartorius Stedim may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Grand Vision Media 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Grand Vision Media has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Grand Vision is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Sartorius Stedim and Grand Vision Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sartorius Stedim and Grand Vision

The main advantage of trading using opposite Sartorius Stedim and Grand Vision positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, Grand Vision can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Grand Vision will offset losses from the drop in Grand Vision's long position.
The idea behind Sartorius Stedim Biotech and Grand Vision Media pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Valuation
Check real value of public entities based on technical and fundamental data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance